Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

53 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Colon perforation in multiple myeloma patients - A complication of high-dose steroid treatment.
Vaxman I, Al Saleh AS, Kumar S, Nitin M, Dispenzieri A, Buadi F, Dingli D, Lacy M, Muchtar E, Hobbs M, Fonder A, Hwa L, Visram A, Kapoor P, Siddiqui M, Lust J, Kyle R, Rajkumar V, Hayman S, Leung N, Gonsalves W, Kourelis T, Warsame R, Gertz MA. Vaxman I, et al. Among authors: hwa l. Cancer Med. 2020 Dec;9(23):8895-8901. doi: 10.1002/cam4.3507. Epub 2020 Oct 6. Cancer Med. 2020. PMID: 33022868 Free PMC article.
Soluble suppression of tumorigenicity 2 (sST2), but not galactin-3, adds to prognostication in patients with systemic AL amyloidosis independent of NT-proBNP and troponin T.
Dispenzieri A, Gertz MA, Saenger A, Kumar SK, Lacy MQ, Buadi FK, Dingli D, Leung N, Zeldenrust S, Hayman SR, Kapoor P, Grogan M, Hwa L, Russell SJ, Go RS, Rajkumar SV, Kyle RA, Jaffe A. Dispenzieri A, et al. Among authors: hwa l. Am J Hematol. 2015 Jun;90(6):524-8. doi: 10.1002/ajh.24001. Epub 2015 Apr 2. Am J Hematol. 2015. PMID: 25753178 Free article. Clinical Trial.
Abnormal FISH in patients with immunoglobulin light chain amyloidosis is a risk factor for cardiac involvement and for death.
Warsame R, Kumar SK, Gertz MA, Lacy MQ, Buadi FK, Hayman SR, Leung N, Dingli D, Lust JA, Ketterling RP, Lin Y, Russell S, Hwa L, Kapoor P, Go RS, Zeldenrust SR, Kyle RA, Rajkumar SV, Dispenzieri A. Warsame R, et al. Among authors: hwa l. Blood Cancer J. 2015 May 1;5(5):e310. doi: 10.1038/bcj.2015.34. Blood Cancer J. 2015. PMID: 25933374 Free PMC article.
Outcomes of primary refractory multiple myeloma and the impact of novel therapies.
Majithia N, Vincent Rajkumar S, Lacy MQ, Buadi FK, Dispenzieri A, Gertz MA, Hayman SR, Dingli D, Kapoor P, Hwa L, Lust JA, Russell SJ, Go RS, Kyle RA, Kumar SK. Majithia N, et al. Among authors: hwa l. Am J Hematol. 2015 Nov;90(11):981-5. doi: 10.1002/ajh.24131. Epub 2015 Oct 6. Am J Hematol. 2015. PMID: 26214732 Free PMC article.
Phase 2 trial of ixazomib in patients with relapsed multiple myeloma not refractory to bortezomib.
Kumar SK, LaPlant B, Roy V, Reeder CB, Lacy MQ, Gertz MA, Laumann K, Thompson MA, Witzig TE, Buadi FK, Rivera CE, Mikhael JR, Bergsagel PL, Kapoor P, Hwa L, Fonseca R, Stewart AK, Chanan-Khan A, Rajkumar SV, Dispenzieri A. Kumar SK, et al. Among authors: hwa l. Blood Cancer J. 2015 Aug 14;5(8):e338. doi: 10.1038/bcj.2015.60. Blood Cancer J. 2015. PMID: 26275080 Free PMC article. Clinical Trial.
Quantification of circulating clonal plasma cells via multiparametric flow cytometry identifies patients with smoldering multiple myeloma at high risk of progression.
Gonsalves WI, Rajkumar SV, Dispenzieri A, Dingli D, Timm MM, Morice WG, Lacy MQ, Buadi FK, Go RS, Leung N, Kapoor P, Hayman SR, Lust JA, Russell SJ, Zeldenrust SR, Hwa L, Kourelis TV, Kyle RA, Gertz MA, Kumar SK. Gonsalves WI, et al. Among authors: hwa l. Leukemia. 2017 Jan;31(1):130-135. doi: 10.1038/leu.2016.205. Epub 2016 Jul 26. Leukemia. 2017. PMID: 27457702 Free PMC article.
Serum free light chain measurements to reduce 24-h urine monitoring in patients with multiple myeloma with measurable urine monoclonal protein.
Tschautscher M, Rajkumar V, Dispenzieri A, Lacy M, Gertz M, Buadi F, Dingli D, Hwa L, Fonder A, Hobbs M, Hayman S, Zeldenrust S, Lust J, Russell S, Leung N, Kapoor P, Go R, Lin Y, Gonsalves W, Kourelis T, Warsame R, Kyle R, Kumar S. Tschautscher M, et al. Among authors: hwa l. Am J Hematol. 2018 Oct;93(10):1207-1210. doi: 10.1002/ajh.25215. Epub 2018 Aug 15. Am J Hematol. 2018. PMID: 30016549 Free article.
Overall survival of transplant eligible patients with newly diagnosed multiple myeloma: comparative effectiveness analysis of modern induction regimens on outcome.
Paquin AR, Kumar SK, Buadi FK, Gertz MA, Lacy MQ, Dispenzieri A, Dingli D, Hwa L, Fonder A, Hobbs M, Hayman SR, Zeldenrust SR, Lust JA, Russell SJ, Leung N, Kapoor P, Go RS, Lin Y, Gonsalves WI, Kourelis T, Warsame R, Kyle RA, Rajkumar SV. Paquin AR, et al. Among authors: hwa l. Blood Cancer J. 2018 Dec 11;8(12):125. doi: 10.1038/s41408-018-0163-7. Blood Cancer J. 2018. PMID: 30538223 Free PMC article.
Implications and outcomes of MRD-negative multiple myeloma patients with immunofixation positivity.
Tschautscher M, Jevremovic D, Buadi FK, Lacy MQ, Gertz MA, Dispenzieri A, Kapoor P, Dingli D, Hwa L, Fonder A, Hobbs M, Hayman S, Lust J, Russell S, Leung N, Go R, Lin Y, Gonsalves W, Kourelis T, Warsame R, Kyle RA, Rajkumar V, Kumar S. Tschautscher M, et al. Among authors: hwa l. Am J Hematol. 2020 Mar;95(3):E60-E62. doi: 10.1002/ajh.25702. Epub 2019 Dec 30. Am J Hematol. 2020. PMID: 31840857 Free article. No abstract available.
53 results